Latest Modern Developments on Oxytocin: Human and Animal Models Studies

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Psychiatry".

Deadline for manuscript submissions: closed (1 July 2022) | Viewed by 5643

Special Issue Editors


E-Mail Website
Guest Editor
Department of Psychiatry, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 16th Universitatii, 700115 Iasi, Romania
Interests: memory; cognitive neuroscience; cognition disorders

Special Issue Information

Dear Colleagues, 

Oxytocin is a nonapeptide hormone that is synthesized in the supraoptic and paraventricular nuclei of the hypothalamus and is directly projected into other brain areas, where it acts as a neurotransmitter.

Recently, several data have suggested that beside the classical roles in parturition and milk letdown, oxytocin could play an important part in the pathophysiology of some psychiatric disorders mainly characterized by impairments in the social functioning. In this way, in this SI, we are proposing a complex interdisciplinary approach regarding (but not limited to) the effects of oxytocin administration (peripheral vs. intranasal) in the pathophysiological manifestations of some animal models of autism, schizophrenia, anxiety and depression etc on rat and zebrafish (e.g. animal models in general), and also on the human patients, as well as any other related or relevant aspects towards these.

Dr. Alin Stelian Ciobică
Dr. Romeo Dobrin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxytocin
  • intranasal
  • autism
  • schizophrenia
  • anxiety
  • depression
  • rat
  • zebrafish
  • animal models
  • human patients

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 408 KiB  
Review
Oxytocin: Narrative Expert Review of Current Perspectives on the Relationship with Other Neurotransmitters and the Impact on the Main Psychiatric Disorders
by Tudor Florea, Matei Palimariciuc, Ana Caterina Cristofor, Irina Dobrin, Roxana Chiriță, Magdalena Bîrsan, Romeo Petru Dobrin and Manuela Pădurariu
Medicina 2022, 58(7), 923; https://doi.org/10.3390/medicina58070923 - 11 Jul 2022
Cited by 7 | Viewed by 5114
Abstract
Is a cyclic neuropeptide produced primarily in the hypothalamus and plays an important neuromodulatory role for other neurotransmitter systems, with an impact on behavior, response to danger, stress, and complex social interactions, such as pair bonding and child care. This narrative expert review [...] Read more.
Is a cyclic neuropeptide produced primarily in the hypothalamus and plays an important neuromodulatory role for other neurotransmitter systems, with an impact on behavior, response to danger, stress, and complex social interactions, such as pair bonding and child care. This narrative expert review examines the literature on oxytocin as a brain hormone. We focused on oxytocin structure, distribution, genetics, and the oxytocin receptor system, as well as the relationship of oxytocin with other neurotransmitters and the resulting impacts on the main psychiatric disorders. Oxytocin levels have been correlated over time with mental illness, with numerous studies focusing on oxytocin and the pathophysiology of the main psychiatric disorders, such as autism, schizophrenia, personality disorders, mood, and eating disorders. We highlight the role oxytocin plays in improving symptoms such as anxiety, depression, and social behavior, as the literature suggests. Risk factors and causes for psychiatric disorders range from genetic to environmental and social factors. Oxytocin could impact the latter, being linked with other neurotransmitter systems that are responsible for integrating different situations during the development phases of individuals. Also, these systems have an important role in how the body responds to stressors or bonding with others, helping with the creation of social support groups that could speed up recovery in many situations. Oxytocin has the potential to become a key therapeutic agent for future treatment and prevention strategies concerning the main psychiatric disorders. Full article
Back to TopTop